ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,379Medicare Part D Prescriptions Filled, Including Refills

Rank: 183 out of 5176

$964K Total Retail Price of All Prescriptions

Rank: 287 out of 5176

508 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 13,746 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,095 904 1 1
MELOXICAM 850 727 2 53
OMEPRAZOLE 820 683 3 3
LOSARTAN-HYDROCHLOROTHIAZIDE 672 555 4 35
METOPROLOL SUCCINATE 516 454 5 11
TRAMADOL HCL 509 450 6 40
SPIRONOLACTONE 509 455 6 88
LOSARTAN POTASSIUM 476 413 8 14
JANUVIA 432 380 9 25
DIOVAN HCT 371 319 10 39
SINGULAIR 371 291 10 62
GLIMEPIRIDE 287 227 12 37
QVAR 265 223 13 324
GLYBURIDE-METFORMIN HCL 263 242 R 14 76
CRESTOR 255 225 15 15
AMLODIPINE BESYLATE 250 228 16 2
FLUTICASONE PROPIONATE 244 194 17 38
NEXIUM 212 142 18 16
MONTELUKAST SODIUM 203 167 19 123
LEVOTHYROXINE SODIUM 197 147 20 4
TAMSULOSIN HCL 194 181 21 20
QUETIAPINE FUMARATE 171 156 22 75
MEGESTROL ACETATE 163 162 R 23 263
ADVAIR DISKUS 163 145 23 32
DICLOFENAC SODIUM 160 127 25 160
SEROQUEL XR 151 94 26 398
JANUMET 151 109 26 77
AMITRIPTYLINE HCL 149 123 R 28 177
ZOLPIDEM TARTRATE 149 104 28 17
LISINOPRIL 146 112 30 5
NAPROXEN 138 109 31 95
FLUOXETINE HCL 131 98 32 132
MECLIZINE HCL 125 102 33 81
HYDROCORTISONE 119 96 34 265
IBUPROFEN 118 95 35 72
ATENOLOL 115 88 36 12
HUMALOG MIX 75-25 113 101 37 381
SEROQUEL 111 103 38 166
TRAMADOL HCL-ACETAMINOPHEN 110 89 39 116
CLOTRIMAZOLE-BETAMETHASONE 107 98 40 94
VENTOLIN HFA 105 92 41 64
METOPROLOL TARTRATE 103 103 42 6
ENALAPRIL MALEATE 103 93 42 22
FUROSEMIDE 103 103 42 8
DIVALPROEX SODIUM ER 102 88 45 270
ALLOPURINOL 94 83 46 41
MICARDIS HCT 91 78 47 180
TRIBENZOR 91 86 47 276
HALOPERIDOL 90 83 49 145
FOSINOPRIL SODIUM 87 75 50 105
HYDROCHLOROTHIAZIDE 87 79 50 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 85 52 49
PROAIR HFA 74 59 53 60
LEFLUNOMIDE 71 55 54 460
CLOPIDOGREL 69 64 55 26
GABAPENTIN 69 54 55 21
PLAVIX 66 62 57 29
METFORMIN HCL 66 57 57 7
AMMONIUM LACTATE 66 61 57 91
SYMBICORT 64 47 60 120
ONGLYZA 63 52 61 153
SERTRALINE HCL 61 59 62 30
CARVEDILOL 60 60 63 24
METHOTREXATE 59 38 64 240
ROPINIROLE HCL 56 56 65 208
ESTRADIOL 56 21 R 65 558
ATORVASTATIN CALCIUM 55 55 67 9
BUPROPION XL 52 51 68 306
LACTULOSE 51 51 69 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.